Literature DB >> 2617363

The long-range prognosis of arachnoiditis.

D W Guyer1, L L Wiltse, M L Eskay, B H Guyer.   

Abstract

Fifty patients with arachnoiditis were studied, and long-term follow-up ranging from 10 to 21 years was obtained on 36 (72%). Prior to developing arachnoiditis, 90% originally had intervertebral disc disease, Pantopaque (Alcon Surgical, Ft. Worth, Texas) myelography, and subsequent lumbar spine surgery. Pain and functional disability tended to remain the same as at the time of diagnosis, although severity of symptoms fluctuated. Increased neurologic deficits were more frequently due to surgical intervention than to the natural course of the disease. Urinary symptoms characterized by urgency, frequency, and occasional incontinence, with no other apparent cause, developed late in 23%. Although the majority were able to walk and drive a car without limitation, ability to return to previous full-time occupations was markedly limited. The majority depended on daily narcotic analgesics; a few admitted to alcohol abuse. There were two deaths by suicide. Although other deaths were not directly related to arachnoiditis, the average lifespan was shortened by 12 years. Treatment results were disappointing. Arachnoiditis may be disabling; however, longterm follow-up indicates that progression of symptoms and functional impairment are not the natural course of the disease.

Entities:  

Mesh:

Year:  1989        PMID: 2617363     DOI: 10.1097/00007632-198912000-00010

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  9 in total

1.  Asymptomatic thoracic Pantopaque cyst mimicking an intradural extramedullary lipoma on MR images.

Authors:  Sang-Kook Lee; Daniel H Kim; Se-Hoon Kim; Dong-Jun Lim
Journal:  Eur Spine J       Date:  2012-05-19       Impact factor: 3.134

2.  Compression of the S1 Nerve Root by an Extradural Vascular Malformation: A Case Report and Discussion of Atypical Causes of Lumbar Radiculopathy.

Authors:  Jeffrey Thompson; Robert K Merrill; Sheeraz A Qureshi; Dante M Leven
Journal:  Int J Spine Surg       Date:  2020-02-29

Review 3.  The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).

Authors:  Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

4.  Delayed occurrence of spinal arachnoiditis following a caudal block.

Authors:  Eun Hye Na; Soo Jeong Han; Myung Hyun Kim
Journal:  J Spinal Cord Med       Date:  2011-11       Impact factor: 1.985

5.  Thoracic arachnoiditis, arachnoid cyst and syrinx formation secondary to myelography with Myodil, 30 years previously.

Authors:  Kanna K Gnanalingham; Shabin Man Joshi; Ian Sabin
Journal:  Eur Spine J       Date:  2006-08-31       Impact factor: 3.134

6.  Spinal arachnoiditis leading to recurrent reversible myelopathy: A case report.

Authors:  Erol Jahja; Charles Sansur; Peter Howard Gorman
Journal:  J Spinal Cord Med       Date:  2020-11-09       Impact factor: 2.040

7.  Syringomyelia associated with spinal arachnoiditis treated by partial arachnoid dissection and syrinx-far distal subarachnoid shunt.

Authors:  Koichi Iwatsuki; Toshiki Yoshimine; Yu-Ichiro Ohnishi; Koshi Ninomiya; Takashi Moriwaki; Toshika Ohkawa
Journal:  Clin Med Insights Case Rep       Date:  2014-09-04

Review 8.  Spinal arachnoiditis and syringomyelia: Review of literature with emphasis on postinfectious inflammation and treatment.

Authors:  Syed Faisal Nadeem; Ahmer Nasir Baig; Qurat Ul Ain Tariq; Muhammad Shahzad Shamim
Journal:  Surg Neurol Int       Date:  2022-07-15

9.  Tumor necrosis factor-α blockade in recurrent and disabling chronic sciatica associated with post-operative peridural lumbar fibrosis: results of a double-blind, placebo randomized controlled study.

Authors:  Christelle Nguyen; Clémence Palazzo; Sophie Grabar; Antoine Feydy; Katherine Sanchez; Nathalie Zee; Laurent Quinquis; Myriam Ben Boutieb; Michel Revel; Marie-Martine Lefèvre-Colau; Serge Poiraudeau; François Rannou
Journal:  Arthritis Res Ther       Date:  2015-11-19       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.